# Amneal Pharmaceuticals, Inc. (AMRX) FY2026 Q2 Balance Sheet

- Company: Amneal Pharmaceuticals, Inc. (AMRX)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-06, accession number 0001723128-26-000031
- Page: https://plicit.ai/financials/amrx/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/amrx-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 3,776,348,000 US dollars
- **Current assets**: 1,947,029,000 US dollars
- **Non-current assets**: 1,829,319,000 US dollars
- **Liabilities (calculated)**: 3,659,368,000 US dollars
- **Current liabilities**: 883,187,000 US dollars
- **Non-current liabilities**: 2,776,181,000 US dollars
- **Equity**: 33,024,000 US dollars
- **Redeemable non-controlling interests**: 83,956,000 US dollars
- **Noncontrolling interest**: 0 US dollars. Included in consolidated equity; this amount is not added again.
- **Receivables - Nonrelated Party**: 1,020,360,000 US dollars
- **Inventories**: 677,954,000 US dollars
- **Cash and cash equivalents**: 127,637,000 US dollars
- **Prepaid expenses and other current assets**: 112,011,000 US dollars
- **Restricted cash**: 8,643,000 US dollars
- **Receivables - Related Party**: 424,000 US dollars
- **Goodwill**: 593,499,000 US dollars
- **Intangible assets, net**: 587,830,000 US dollars
- **Property, plant and equipment, net**: 456,877,000 US dollars
- **Other assets**: 80,669,000 US dollars
- **Financing lease right-of-use assets - Nonrelated Party**: 52,360,000 US dollars
- **Operating lease right-of-use assets - Nonrelated Party**: 44,361,000 US dollars
- **Operating lease right-of-use assets - Related Party**: 13,723,000 US dollars
- **Accounts payable and accrued expenses - Nonrelated Party**: 721,208,000 US dollars
- **Revolving credit facility**: 100,000,000 US dollars
- **Accounts payable and accrued expenses - Related Party**: 22,070,000 US dollars
- **Current portion of liabilities for legal matters**: 18,488,000 US dollars
- **Current portion of operating lease liabilities - Nonrelated Party**: 9,040,000 US dollars
- **Current portion of long-term debt, net**: 5,961,000 US dollars
- **Current portion of financing lease liabilities - Nonrelated Party**: 3,521,000 US dollars
- **Current portion of operating lease liabilities - Related Party**: 2,899,000 US dollars
- **Long-term debt, net**: 2,564,335,000 US dollars
- **Liabilities for legal matters - long term**: 70,830,000 US dollars
- **Financing lease liabilities - Nonrelated Party**: 54,602,000 US dollars
- **Operating lease liabilities - Nonrelated Party**: 38,691,000 US dollars
- **Related party payables - long term - Nonrelated Party**: 32,119,000 US dollars
- **Operating lease liabilities - Related Party**: 12,712,000 US dollars
- **Related party payables - long term - Related Party**: 2,892,000 US dollars
- **Additional paid-in capital**: 545,584,000 US dollars
- **Common stock - Common Class A**: 3,193,000 US dollars
- **Preferred stock, $0.01 par value, 2,000 shares authorized at both June 30, 2026 and December 31, 2025; none issued at both June 30, 2026 and December 31, 2025**: 0 US dollars
- **Common stock - Common Class B**: 0 US dollars
- **Non-controlling interests**: 0 US dollars
- **Stockholders’ accumulated deficit**: negative 415,087,000 US dollars
- **Accumulated other comprehensive loss**: negative 100,666,000 US dollars
- **Gross equity (calculated)**: 548,777,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus temporary equity plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.